CD8A and neoplasm: In a transgenic mouse model of HPV-transformed cancer, Lm-LLO-E7 was shown to overcome tumor-induced central tolerance by expanding low-avidity and low-frequency E7-specific CD8+ T cells, which eradicate E7-expressing thyroid mouse tumors [38].